Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

January 2000

Volume 909 NEW MEDICATIONS FOR DRUG ABUSE

Pages ix–x, 1–279

  1. Frontmatter

    1. Top of page
    2. Frontmatter
    3. New Medications for Drug Abusea: Part I. New Approaches to the Treatment of Pain
    4. New Medications for Drug Abusea: Part II. Bridging the Gap between Addicts and Animal Models: Developing New Treatments for Stimulant and Opioid Addiction
    5. New Medications for Drug Abusea: Part III. Preclinical Assessment of New Pharmacotherapies for Cocaine Dependence
    6. New Medications for Drug Abusea: Part IV. Neurobiological Mechanisms of Drug Dependence: Implications for Understanding and Treating Drug Abuse
    7. New Medications for Drug Abusea: Part V. Large-Scale Issues: Developing New Treatments for Alcoholism and Smoking, the Consequences of Prenatal Cocaine Exposure, and the Past and Future of Methadone and Related Treatments
    8. New Medications for Drug Abusea: Part VI. Poster Presentations
    1. Preface (pages ix–x)

      Stanley D. Glick

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06671.x

  2. New Medications for Drug Abusea: Part I. New Approaches to the Treatment of Pain

    1. Top of page
    2. Frontmatter
    3. New Medications for Drug Abusea: Part I. New Approaches to the Treatment of Pain
    4. New Medications for Drug Abusea: Part II. Bridging the Gap between Addicts and Animal Models: Developing New Treatments for Stimulant and Opioid Addiction
    5. New Medications for Drug Abusea: Part III. Preclinical Assessment of New Pharmacotherapies for Cocaine Dependence
    6. New Medications for Drug Abusea: Part IV. Neurobiological Mechanisms of Drug Dependence: Implications for Understanding and Treating Drug Abuse
    7. New Medications for Drug Abusea: Part V. Large-Scale Issues: Developing New Treatments for Alcoholism and Smoking, the Consequences of Prenatal Cocaine Exposure, and the Past and Future of Methadone and Related Treatments
    8. New Medications for Drug Abusea: Part VI. Poster Presentations
    1. Partial Opioids: Medications for the Treatment of Pain and Drug Abuse (pages 1–11)

      JEAN M. BIDLACK, JAY P. McLAUGHLIN and MARK P. WENTLAND

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06672.x

    2. Spinal and Supraspinal Mechanisms of Neuropathic Pain (pages 12–24)

      MICHAEL H. OSSIPOV, JOSEPHINE LAI, T. PHILIP MALAN JR. and FRANK PORRECA

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06673.x

    3. A Third Life for Burimamide: Discovery and Characterization of a Novel Class of Non-Opioid Analgesics Derived from Histamine Antagonists (pages 25–40)

      LINDSAY B. HOUGH, JULIA W. NALWALK, WILLIAM G. BARNES, ROB LEURS, WIRO M. P. B. MENGE, HENK TIMMERMAN and MARK WENTLAND

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06674.x

    4. Peripheral Opioid Modulation of Visceral Pain (pages 41–50)

      G. F. GEBHART, XIN SU, SHAILEN JOSHI, N. OZAKI and J. N. SENGUPTA

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06675.x

  3. New Medications for Drug Abusea: Part II. Bridging the Gap between Addicts and Animal Models: Developing New Treatments for Stimulant and Opioid Addiction

    1. Top of page
    2. Frontmatter
    3. New Medications for Drug Abusea: Part I. New Approaches to the Treatment of Pain
    4. New Medications for Drug Abusea: Part II. Bridging the Gap between Addicts and Animal Models: Developing New Treatments for Stimulant and Opioid Addiction
    5. New Medications for Drug Abusea: Part III. Preclinical Assessment of New Pharmacotherapies for Cocaine Dependence
    6. New Medications for Drug Abusea: Part IV. Neurobiological Mechanisms of Drug Dependence: Implications for Understanding and Treating Drug Abuse
    7. New Medications for Drug Abusea: Part V. Large-Scale Issues: Developing New Treatments for Alcoholism and Smoking, the Consequences of Prenatal Cocaine Exposure, and the Past and Future of Methadone and Related Treatments
    8. New Medications for Drug Abusea: Part VI. Poster Presentations
    1. Neurobiological Adaptations to Psychostimulants and Opiates as a Basis of Treatment Development (pages 51–87)

      KEVIN A. SEVARINO, ALISON OLIVETO and THOMAS R. KOSTEN

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06676.x

    2. Development of Novel Medications for Drug Addiction: The Legacy of an African Shrub (pages 88–103)

      STANLEY D. GLICK and ISABELLE M. MAISONNEUVE

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06677.x

  4. New Medications for Drug Abusea: Part III. Preclinical Assessment of New Pharmacotherapies for Cocaine Dependence

    1. Top of page
    2. Frontmatter
    3. New Medications for Drug Abusea: Part I. New Approaches to the Treatment of Pain
    4. New Medications for Drug Abusea: Part II. Bridging the Gap between Addicts and Animal Models: Developing New Treatments for Stimulant and Opioid Addiction
    5. New Medications for Drug Abusea: Part III. Preclinical Assessment of New Pharmacotherapies for Cocaine Dependence
    6. New Medications for Drug Abusea: Part IV. Neurobiological Mechanisms of Drug Dependence: Implications for Understanding and Treating Drug Abuse
    7. New Medications for Drug Abusea: Part V. Large-Scale Issues: Developing New Treatments for Alcoholism and Smoking, the Consequences of Prenatal Cocaine Exposure, and the Past and Future of Methadone and Related Treatments
    8. New Medications for Drug Abusea: Part VI. Poster Presentations
    1. Interactions between Kappa Opioid Agonists and Cocaine: Preclinical Studies (pages 104–132)

      NANCY K. MELLO and S. STEVENS NEGUS

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06678.x

    2. Effects of the Novel D1 Dopamine Receptor Agonist ABT-431 on Cocaine Self-Administration and Reinstatement (pages 133–144)

      DAVID W. SELF, DAVID A. KARANIAN and JENNIFER J. SPENCER

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06679.x

    3. GABA Modulation of Cocaine Self-Administration (pages 145–158)

      DAVID C.S. ROBERTS and KAREN BREBNER

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06680.x

    4. Application of Artificial Enzymes to the Problem of Cocaine (pages 159–169)

      PALOMA DE PRADA, GAIL WINGER and DONALD W. LANDRY

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06681.x

  5. New Medications for Drug Abusea: Part IV. Neurobiological Mechanisms of Drug Dependence: Implications for Understanding and Treating Drug Abuse

    1. Top of page
    2. Frontmatter
    3. New Medications for Drug Abusea: Part I. New Approaches to the Treatment of Pain
    4. New Medications for Drug Abusea: Part II. Bridging the Gap between Addicts and Animal Models: Developing New Treatments for Stimulant and Opioid Addiction
    5. New Medications for Drug Abusea: Part III. Preclinical Assessment of New Pharmacotherapies for Cocaine Dependence
    6. New Medications for Drug Abusea: Part IV. Neurobiological Mechanisms of Drug Dependence: Implications for Understanding and Treating Drug Abuse
    7. New Medications for Drug Abusea: Part V. Large-Scale Issues: Developing New Treatments for Alcoholism and Smoking, the Consequences of Prenatal Cocaine Exposure, and the Past and Future of Methadone and Related Treatments
    8. New Medications for Drug Abusea: Part VI. Poster Presentations
  6. New Medications for Drug Abusea: Part V. Large-Scale Issues: Developing New Treatments for Alcoholism and Smoking, the Consequences of Prenatal Cocaine Exposure, and the Past and Future of Methadone and Related Treatments

    1. Top of page
    2. Frontmatter
    3. New Medications for Drug Abusea: Part I. New Approaches to the Treatment of Pain
    4. New Medications for Drug Abusea: Part II. Bridging the Gap between Addicts and Animal Models: Developing New Treatments for Stimulant and Opioid Addiction
    5. New Medications for Drug Abusea: Part III. Preclinical Assessment of New Pharmacotherapies for Cocaine Dependence
    6. New Medications for Drug Abusea: Part IV. Neurobiological Mechanisms of Drug Dependence: Implications for Understanding and Treating Drug Abuse
    7. New Medications for Drug Abusea: Part V. Large-Scale Issues: Developing New Treatments for Alcoholism and Smoking, the Consequences of Prenatal Cocaine Exposure, and the Past and Future of Methadone and Related Treatments
    8. New Medications for Drug Abusea: Part VI. Poster Presentations
    1. Prenatal Cocaine Exposure (pages 217–232)

      RICHARD W. KELLER JR. and ABIGAIL SNYDER-KELLER

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06684.x

    2. Mimicking Gene Defects to Treat Drug Dependence (pages 233–246)

      EDWARD M. SELLERS and RACHEL F. TYNDALE

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06685.x

    3. Tobacco Dependence: Global Public Health Potential for New Medications Development and Indications (pages 247–256)

      JACK E. HENNINGFIELD, REGINALD V. FANT, JOSEPH GITCHELL and SAUL SHIFFMAN

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06686.x

  7. New Medications for Drug Abusea: Part VI. Poster Presentations

    1. Top of page
    2. Frontmatter
    3. New Medications for Drug Abusea: Part I. New Approaches to the Treatment of Pain
    4. New Medications for Drug Abusea: Part II. Bridging the Gap between Addicts and Animal Models: Developing New Treatments for Stimulant and Opioid Addiction
    5. New Medications for Drug Abusea: Part III. Preclinical Assessment of New Pharmacotherapies for Cocaine Dependence
    6. New Medications for Drug Abusea: Part IV. Neurobiological Mechanisms of Drug Dependence: Implications for Understanding and Treating Drug Abuse
    7. New Medications for Drug Abusea: Part V. Large-Scale Issues: Developing New Treatments for Alcoholism and Smoking, the Consequences of Prenatal Cocaine Exposure, and the Past and Future of Methadone and Related Treatments
    8. New Medications for Drug Abusea: Part VI. Poster Presentations
    1. Ibogaine in Acute Opioid Withdrawal: An Open Label Case Series (pages 257–259)

      KENNETH R. ALPER, HOWARD S. LOTSOF, GEERTE M. N. FRENKEN, DANIEL J. LUCIANO and JAN BASTIAANS

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06687.x

    2. Methamphetamine Quantitative Urine Concentrations during a Controlled Trial of Fluoxetine Treatment: Preliminary Analysis (pages 260–263)

      S. L. BATKI, J. MOON, K. DELUCCHI, M. BRADLEY, D. HERSH, S. SMOLAR, M. MENGIS, E. LEFKOWITZ, D. SEXE, L. MORELLO, T. EVERHART, R. T. JONES and P. JACOB III

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06688.x

    3. Synchronous Activity in the Ventral Tegmental Area and Prefrontal Cortex (pages 267–269)

      YVETTE M. PETERS, BARBARA L. LEWIS and PATRICIO O'DONNELL

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06691.x

    4. Histamine Modulation of Nucleus Accumbens Neurons (pages 270–272)

      JAMES SHOBLOCK and PATRICIO O'DONNELL

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06692.x

    5. Dopaminergic Mechanisms in Relapse to Cocaine-Seeking Behavior: Implications for Medications Development (pages 273–274)

      R. D. SPEALMAN, T. V. KHROYAN, R. L. BARRETT-LARIMORE, J. K. ROWLETT and D. M. PLATT

      Version of Record online: 25 JAN 2006 | DOI: 10.1111/j.1749-6632.2000.tb06693.x

SEARCH

SEARCH BY CITATION